iBio, Inc. Common Stock (IBIO)

NASDAQ HEALTHCARE
$1.69 +4.32% RSI 31 Neutral Add Alert

Moving Averages

SMA 200
$1.48
Price above

Company Profile

iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$74.61M
P/E Ratio
None
EPS
$-1
Beta
1.361
Dividend Yield
0.00%
52-Week High
$3.82
52-Week Low
$0.56

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 54.0
VRTX
Vertex Pharmaceuticals Inc
RSI 37.0
CRSP
CRISPR Therapeutics AG
RSI 46.0
MRNA
Moderna Inc
RSI 35.0
VKTX
Viking Therapeutics Inc
RSI 39.0
SRPT
Sarepta Therapeutics Inc
RSI 50.0

Data last updated: April 11, 2026 at 2:54 PM EDT

Track IBIO for free

Get e-mail RSI alerts when iBio, Inc. Common Stock enters oversold or overbought territory. Free forever.

Add Alert